Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Research and development spending
3Y CAGR
+43.1%/yr
vs +12.4%/yr prior
5Y CAGR
+23.5%/yr
Recent acceleration
Acceleration
+30.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.9x
Strong expansion
Streak
4 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $171.65M | +5.4% |
| 2024 | $162.79M | +81.9% |
| 2023 | $89.50M | +52.8% |
| 2022 | $58.58M | +2.6% |
| 2021 | $57.07M | -4.3% |
| 2020 | $59.64M | -7.7% |
| 2019 | $64.60M | +75.9% |
| 2018 | $36.72M | +60.9% |
| 2017 | $22.82M | +25.8% |
| 2016 | $18.14M | - |